Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Par Sterile Products, LLC
EIR
•Par Sterile Products, LLC•April 15, 2019

Par Sterile Products, LLC – FDA EIR, Apr 15, 2019

Record Details

An FDA inspection of PAR Sterile Products LLC, a sterile drug manufacturer located in Rochester, MI, was conducted from April 8 to April 15, 2019. This comprehensive surveillance inspection, carried out under current Good Manufacturing Practices (cGMP), identified significant issues primarily concerning record-keeping and procedural adherence. The main violation, formalized in an FDA Form 483, highlighted deficiencies in batch production and control records. Specifically, the firm failed to adequately document significant manufacturing steps, including the contemporaneous verification of rejected vial counts and timely signatures for completed activities. The report noted instances where supporting documents lacked specific, relevant information, thereby not fully substantiating critical entries. This finding referenced 21 CFR 211.188(b) regarding general requirements for batch production and control records. Beyond the formal observation, the inspection included verbal discussions with management on several other concerns. These covered aspects of complaint handling, the methodology for Acceptance Quality Limit (AQL) sampling for small batch sizes, and the process for sampling incoming Active Pharmaceutical Ingredients (API). The report also noted an issue with the robustness of the Argatroban assay method and the firm's policy of only conducting visual inspections on returned product samples, which could impede comprehensive root cause investigations. In response to the FDA 483, PAR Sterile Products LLC management committed to submitting a written reply within 15 business days addressing the identified deficiencies.

Company
Par Sterile Products, LLC
Inspection date
April 15, 2019
Product type
drugs
Office
Detroit District Office
People
  • Amy Graf
  • Joseph T. Madak (investigator)
  • Shirshendu K. Deb (investigator)
  • Sarah E. Rhoades (Investigator)
View Company Profile

ID · d06f7f8b-8a3d-4916-9fd3-a281a2fdc2fd

Violation Codes2
21 CFR 820.19821 CFR 211.188(b)

Full citation text and observation details available on the Dashboard.

Other documents for Par Sterile Products, LLC
  • CRL

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Par Sterile Products, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.